Apnimed, Inc. Common Stock (APMD) — Working Capital to Net Assets Ratio
Apnimed, Inc. Common Stock (APMD) has a Working Capital to Net Assets ratio of 114.0% as of March 2026. Working capital of $293.61 Million (current assets of $332.00 Million minus current liabilities of $38.39 Million) is measured against net assets of $257.59 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see balance sheet size of Apnimed, Inc. Common Stock.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Apnimed, Inc. Common Stock Working Capital to Net Assets (2024–2025)
This chart shows how Apnimed, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the ratio stands at 114.0%, reflecting working capital of $293.61 Million against net assets of $257.59 Million USD. Check APMD operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Annual Working Capital to Net Assets for Apnimed, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Apnimed, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read debt load of Apnimed, Inc. Common Stock for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 17.7% | $-65.82 Million | $-372.78 Million | $45.05 Million | $110.88 Million | ▲ +30.1 pp |
| 2024 | -12.4% | $30.89 Million | $-248.62 Million | $73.25 Million | $42.36 Million | — |